tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (ES:ORY)
BME:ORY

Oryzon Genomics SA (ORY) Revenue

Compare
16 Followers

Oryzon Genomics SA Revenue

Oryzon Genomics SA had a revenue of 7.36M in the quarter ending Dec 31, 2024, with Infinity%. This bring the company's revenue in the last twelve months to 11.47M, Increased -37.34%. In the fiscal year ending Dec 31, 2024, Oryzon Genomics SA had annual revenue of 7.36M with -48.15% growth.
Revenue (ttm)
11.47M
Revenue Growth
P/S Ratio
29.39
Revenue/Employee
€156,574
Employees
47
Market Cap
€216.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.36M-6.83M-48.15%
Dec 31, 2023
14.19M-1.51M-9.59%
Dec 31, 2022
15.70M5.08M+47.89%
Dec 31, 2021
10.62M1.09M+11.49%
Dec 31, 2020
9.52M+∞%
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis